HEALTHSPANRequest consultationCLINICAL EVIDENCE INDEXUPDATED 08 / 2026
Human outcomes and guideline-supported uses come first, with direct links to the research behind every IVLV Healthspan offering.
4 offerings indexed
Guidelines support testosterone therapy only for men with compatible symptoms and consistently low testosterone confirmed by appropriate testing.
MonitoringFollow-up combines how you feel with repeat testosterone, hematocrit, and other targeted measures so the plan can be refined over time.
Randomized trials in selected men with secondary hypogonadism found increased testosterone while sperm concentration was preserved compared with topical testosterone.
MonitoringFollow-up tracks symptoms, hormone levels, fertility goals, and response so dose and timing can be refined.
Sildenafil and tadalafil are established PDE5-inhibitor treatments for erectile dysfunction when prescribed in standard oral formulations to appropriate patients.
MonitoringYour physician matches the medication and schedule to your cardiovascular health, current medications, desired timing, and response.
Sildenafil and tadalafil are established treatments for erectile dysfunction. Customized dissolving-tablet formulas with oxytocin offer another route for an individualized plan.
MonitoringYour physician selects the combination and schedule using your health history, current medications, preferred timing, and response.
3 offerings indexed
The linked randomized trial studied once-weekly injectable tirzepatide and found substantial weight reduction in eligible adults alongside lifestyle intervention. It provides background for a physician conversation about formulation-specific options.
MonitoringFollow-up tracks weight trend, appetite, metabolic measures, and how the selected plan feels, allowing dose and support to be refined over time.
The linked randomized trial studied once-weekly injectable semaglutide 2.4 mg and found substantial weight reduction in eligible adults alongside lifestyle intervention. It provides background for a physician conversation about formulation-specific options.
MonitoringFollow-up tracks weight trend, appetite, metabolic measures, and how the selected plan feels, allowing dose and support to be refined over time.
Guidelines support individualized obesity pharmacotherapy alongside lifestyle intervention. Metformin and naltrexone are oral options a physician may consider based on metabolic profile, goals, and current medications.
MonitoringFollow-up tracks weight, waist, relevant metabolic markers, and your experience with the selected medication so the plan can evolve.
3 offerings indexed
Topical minoxidil has randomized-trial evidence for androgenetic alopecia and is an established treatment option.
MonitoringThe physician confirms the hair-loss pattern, establishes baseline photographs, and follows density, coverage, and scalp comfort over time.
Topical minoxidil and topical finasteride each have human trial data for androgenetic alopecia, including a phase III topical-finasteride study.
MonitoringBaseline photographs and follow-up visits track density, coverage, scalp comfort, and response over several months so the formula can be refined.
A small randomized human study of a topical complex containing GHK peptide reported improved hair-count measures over six months. Healthspan uses that research as background for an individualized GHK-Cu scalp plan.
MonitoringBaseline photographs and follow-up track coverage, density, scalp comfort, and visible response over time.
PRIMARY SOURCES → PERSONAL PLANNEXT STEP
Bring your goals and questions to a private physician conversation. We will connect the evidence to the option, route, and follow-up that fit you.